Cortexyme Inc.

💊 Neuropharmaceuticals· 📍 San Francisco, CA, USA

Overview

Cortexyme develops small-molecule therapeutics targeting bacterial pathogens linked to Alzheimer's disease neuroinflammation and neurodegeneration.

Neuralstem Inc.

Germantown, MD, USA

Neurogenix Therapeutics

Basel, Switzerland

Acadia Pharmaceuticals

San Diego, USA

Acer Therapeutics

Newton, MA, USA

Praxis Precision Medicine

Cambridge, MA, USA

Axsome Therapeutics

New York, USA

FDA Grants De Novo Approval to Modius Spero Neuromodulation Device for PTSD

2026-07-27 · Policy

BRYM Raises €650K to Build Wearable Neurofeedback Platform for Consumer and Clinical Markets

2026-07-26 · Funding

ReVision Implant Secures €4 Million to Advance Next-Generation Visual Neuroprosthetics

2026-07-25 · Funding

Flourish Emerges from Stealth with Bezos and Google Ventures Backing to Advance Neuroscience Therapeutics

2026-07-24 · Funding

Claim this listing to add your logo, full description, team, and products. Premium listings get featured placement.

Advertise

Newsletter sponsorships, featured listings, and sponsored articles.